VHL in Kidney Cancer Flashcards
Oxygen is an essential component for life on earth
proving a fundamental element in the survival of aerobic organisms
In normal oxygen environments
mitochondria consume 90% oxygen available
34 ATP per glucose molecule
oxidative phosphorylation
Hypoxia
demand exceeds supply
high altitude and disease
oxygen sensing pathways to increase oxygen supply to tissues
HIF
hypoxia inducible factor
3 isoforms
degraded in normoxia
stabilised in hypoxia
HIF degradation
normoxia
10% oxygen
prolyl hydroxylase enzymes
proline residues to HIF1a
recognised by VHL
proteosomal degradation
HIF stabilisation
hypoxia
100% oxygen to the mitochondria
VHL cannot degrade HIF1a
HIF1b dimerisation in nucleus
Transcription of target genes
Increase oxygen
VHL
Von hippel lindau
VHL disease - kidney tumours
Loss or mutation
Pseudohypoxia
HIF1a and HIF2a binding to HRE
Hypoxia response elements
50 identified
Cancer hallmarks
VHL tumour suppressor protein
Kidney cancer
Kidney cancer
2-3% cases
650 in ireland each year
blood in urine
lump/pain in kidney
tiredness/weakness
can be early detected
hard to treat if metastatic
renal cell carcinoma
85% kidney cancers
ccRCC most common
histological appearance
lipid accumulation
VHL and ccRCC
90% of people with ccRCC have a mutation in VHL
No other gene perturbed to this level
Pseudohypoxia - cancer hallmarks
Relationship of VHL and ccRCC evident
HIF2 and HIF1a in Kidney cancer
HIF2 promotes (tumour promoter)
Agonism increased tumour volume and weight
HIF1 debated role
May act in early and redundant
HIF1 may be an oncogene
Ways HIF2 promotes cancer hallmarks in ccRCC
Raval et al. 2005
Plin2
Cyclin-D1
TGFa
VEGF
GAL3ST1
Plin2
increased lipid droplet formation - characteristic of ccRCC
CyclinD1 and TGFa
Cell proliferation